An in vitro 96-well plate assay of the mitogen-activated protein kinase cascade |
| |
Authors: | Antonsson B Marshall C J Montessuit S Arkinstall S |
| |
Affiliation: | Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S. A., 1228 Plan-les-Ouates, Geneva, Switzerland. bruno.antonsson.ch_gva@serono.com |
| |
Abstract: | Mitogen-activated protein (MAP) kinases of the extracellular signal-regulated kinase (ERK) family are activated in response to many growth and differentiation factors as well as some oncogenes. ERK activation follows phosphorylation by a class of specific upstream MAP kinase/ERK kinase (MEK) exemplified by MEK-1. Activated ERKs control many short- and long-term changes in cell function through phosphorylating a number of intracellular target substrates which include stathmin, a phosphoprotein regulating microtubule stability. We report here the development of a simple, 96-well plate, quantitative in vitro assay measuring purified ERK2 catalytic activation by a constitutive MEK-1 mutant (S218E S222E). Enzymatic activity was detected by 33P phosphorylation of purified biotinylated stathmin captured on streptavidin-coated scintillation proximity assay beads which eliminates the need for wash steps. The assay was optimized and the K0.5 value for ATP was found to be 0.9 microM and the Km for stathmin was determined to be 16 microM. The assay was also used to determine IC50 values for the protein kinase inhibitors PD98059 and staurosporine. This simple assay allows several hundred quantitative measurements of MEK1-dependent ERK2 activation to be performed in a day. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|